<?xml version="1.0" encoding="UTF-8"?>
<p>Other evidence exists on the factors related to uptake and continuation of PrEP in sub-Saharan Africa; however, this evidence comes almost exclusively from participants in clinical trials or other population-targeted programs. PrEP has been described by clients as an HIV prevention tool that allows the user to control their life with minimal cooperation from their partner, especially when condom negotiation is difficult or as additional protection [
 <xref rid="pone.0227632.ref008" ref-type="bibr">8</xref>]. Perceived risk is suggested to be key for uptake and support for adherence to PrEP by partners and has been highlighted as critical to continued use [
 <xref rid="pone.0227632.ref009" ref-type="bibr">9</xref>]. In Kenya, Tanzania, and South Africa, adherence was also facilitated by establishing a routine for taking PrEP [
 <xref rid="pone.0227632.ref010" ref-type="bibr">10</xref>]. However, stigma was also expressed as a barrier to taking PrEP [
 <xref rid="pone.0227632.ref011" ref-type="bibr">11</xref>].
</p>
